Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in...
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), said that the European...
Microbiome Industry Explores Hong Kong As APAC Region Centre
To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty...
Price Negotiations For 10 US Prescription Drugs To Be Shared
A senior Biden White House official said on January 11 that the U.S. administration will...
Antibiotics Shortage Challenge- A Growing Concern For Europe
According to Stella Kyriakides, the EU Health Commissioner, the thought about changes to EU pharmaceutical...
FDA Wraps Up The REMS Standards For Prescription Medicines
The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The...
United States-Switzerland Strike A Drug Inspection Accord
The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good...
5 FDA Announcements To Pay Attention To In The 2023 Q1
The biotechnology sector had a decline in 2022 that went beyond just falling stock prices....
Watch Out For These Potential Best-Seller Drugs In 2023
In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential...
Study Reveals That Gut Microbiome Is Crucial In Parkinsons
Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with...
